TY - JOUR AU - Gordon, D. J. AU - Probstfield, J. L. AU - Garrison, R. J. AU - Neaton, J. D. AU - Castelli, W. P. AU - Knoke, J. D. AU - Jacobs, D. R. AU - Bangdiwala, S. AU - Tyroler, H. A. PY - 1989 DA - 1989// TI - High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies JO - Circulation VL - 79 UR - https://doi.org/10.1161/01.CIR.79.1.8 DO - 10.1161/01.CIR.79.1.8 ID - Gordon1989 ER - TY - JOUR AU - Julve, J. AU - Llaverias, G. AU - Blanco-Vaca, F. AU - Escolà-Gil, J. C. PY - 2011 DA - 2011// TI - Seeking novel targets for improving in vivo macrophage-specific reverse cholesterol transport: translating basic science into new therapies for the prevention and treatment of atherosclerosis JO - Curr Vasc Pharmacol VL - 9 UR - https://doi.org/10.2174/157016111794519264 DO - 10.2174/157016111794519264 ID - Julve2011 ER - TY - JOUR AU - Fielding, C. J. AU - Fielding, P. E. PY - 1982 DA - 1982// TI - Cholesterol transport between cells and body fluids. Role of plasma lipoproteins and the plasma cholesterol esterification system JO - Med Clin North Am VL - 66 ID - Fielding1982 ER - TY - JOUR AU - Cuchel, M. AU - Lund-Katz, S. AU - de la Llera-Moya, M. AU - Millar, J. S. AU - Chang, D. AU - Fuki, I. AU - Rothblat, G. H. AU - Phillips, M. C. AU - Rader, D. J. PY - 2010 DA - 2010// TI - Pathways by which reconstituted high-density lipoprotein mobilizes free cholesterol from whole body and from macrophages JO - Arterioscler Thromb Vasc Biol VL - 30 UR - https://doi.org/10.1161/ATVBAHA.109.196105 DO - 10.1161/ATVBAHA.109.196105 ID - Cuchel2010 ER - TY - JOUR AU - Badimon, J. J. AU - Badimon, L. AU - Galvez, A. AU - Dische, R. AU - Fuster, V. PY - 1989 DA - 1989// TI - High density lipoprotein plasma fractions inhibit aortic fatty streaks in cholesterol-fed rabbits JO - Lab Invest VL - 60 ID - Badimon1989 ER - TY - JOUR AU - Badimon, J. J. AU - Badimon, L. AU - Fuster, V. PY - 1990 DA - 1990// TI - Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit JO - J Clin Invest VL - 85 UR - https://doi.org/10.1172/JCI114558 DO - 10.1172/JCI114558 ID - Badimon1990 ER - TY - JOUR AU - Ibañez, B. AU - Vilahur, G. AU - Cimmino, G. AU - Speidl, W. S. AU - Pinero, A. AU - Choi, B. G. AU - Zafar, M. U. AU - Santos-Gallego, C. G. AU - Krause, B. AU - Badimon, L. AU - Fuster, V. AU - Badimon, J. J. PY - 2008 DA - 2008// TI - Rapid change in plaque size, composition, and molecular footprint after recombinant apolipoprotein A-I Milano (ETC-216) administration: magnetic resonance imaging study in an experimental model of atherosclerosis JO - J Am Coll Cardiol VL - 51 UR - https://doi.org/10.1016/j.jacc.2007.09.071 DO - 10.1016/j.jacc.2007.09.071 ID - Ibañez2008 ER - TY - JOUR AU - Lee, J. M. AU - Robson, M. D. AU - Yu, L. M. AU - Shirodaria, C. C. AU - Cunnington, C. AU - Kylintireas, I. AU - Digby, J. E. AU - Bannister, T. AU - Handa, A. AU - Wiesmann, F. AU - Durrington, P. N. AU - Channon, K. M. AU - Neubauer, S. AU - Choudhury, R. P. PY - 2009 DA - 2009// TI - Effects of high-dose modified-release nicotinic acid on atherosclerosis and vascular function: a randomized, placebo-controlled, magnetic resonance imaging study JO - J Am Coll Cardiol VL - 54 UR - https://doi.org/10.1016/j.jacc.2009.06.036 DO - 10.1016/j.jacc.2009.06.036 ID - Lee2009 ER - TY - JOUR AU - Lewis, G. F. PY - 2006 DA - 2006// TI - Determinants of plasma HDL concentrations and reverse cholesterol transport JO - Curr Opin Cardiol VL - 21 UR - https://doi.org/10.1097/01.hco.0000231405.76930.a0 DO - 10.1097/01.hco.0000231405.76930.a0 ID - Lewis2006 ER - TY - JOUR AU - Assmann, G. AU - Nofer, J. R. PY - 2003 DA - 2003// TI - Atheroprotective effects of high-density lipoproteins JO - Annu Rev Med VL - 54 UR - https://doi.org/10.1146/annurev.med.54.101601.152409 DO - 10.1146/annurev.med.54.101601.152409 ID - Assmann2003 ER - TY - JOUR AU - Barter, P. J. AU - Nicholls, S. AU - Rye, K. A. AU - Anantharamaiah, G. M. AU - Navab, M. AU - Fogelman, A. M. PY - 2004 DA - 2004// TI - Antiinflammatory properties of HDL JO - Circ Res VL - 95 UR - https://doi.org/10.1161/01.RES.0000146094.59640.13 DO - 10.1161/01.RES.0000146094.59640.13 ID - Barter2004 ER - TY - JOUR AU - Okura, H. AU - Yamashita, S. AU - Ohama, T. AU - Saga, A. AU - Yamamoto-Kakuta, A. AU - Hamada, Y. AU - Sougawa, N. AU - Ohyama, R. AU - Sawa, Y. AU - Matsuyama, A. PY - 2010 DA - 2010// TI - HDL/apolipoprotein A-I binds to macrophage-derived progranulin and suppresses its conversion into proinflammatory granulins JO - J Atheroscler Thromb VL - 17 UR - https://doi.org/10.5551/jat.3921 DO - 10.5551/jat.3921 ID - Okura2010 ER - TY - JOUR AU - Barter, P. J. AU - Baker, P. W. AU - Rye, K. A. PY - 2002 DA - 2002// TI - Effect of high-density lipoproteins on the expression of adhesion molecules in endothelial cells JO - Curr Opin Lipidol VL - 13 UR - https://doi.org/10.1097/00041433-200206000-00008 DO - 10.1097/00041433-200206000-00008 ID - Barter2002 ER - TY - JOUR AU - Nofer, J. R. AU - Geigenmüller, S. AU - Göpfert, C. AU - Assmann, G. AU - Buddecke, E. AU - Schmidt, A. PY - 2003 DA - 2003// TI - High density lipoprotein-associated lysosphingolipids reduce E-selectin expression in human endothelial cells JO - Biochem Biophys Res Commun VL - 310 UR - https://doi.org/10.1016/j.bbrc.2003.08.126 DO - 10.1016/j.bbrc.2003.08.126 ID - Nofer2003 ER - TY - JOUR AU - Theilmeier, G. AU - De Geest, B. AU - Van Veldhoven, P. P. AU - Stengel, D. AU - Michiels, C. AU - Lox, M. AU - Landeloos, M. AU - Chapman, M. J. AU - Ninio, E. AU - Collen, D. AU - Himpens, B. AU - Holvoet, P. PY - 2000 DA - 2000// TI - HDL-associated PAF-AH reduces endothelial adhesiveness in apoE-/- mice JO - FASEB J VL - 14 UR - https://doi.org/10.1096/fj.99-1029com DO - 10.1096/fj.99-1029com ID - Theilmeier2000 ER - TY - JOUR AU - Puranik, R. AU - Bao, S. AU - Nobecourt, E. AU - Nicholls, S. J. AU - Dusting, G. J. AU - Barter, P. J. AU - Celermajer, D. S. AU - Rye, K. A. PY - 2008 DA - 2008// TI - Low dose apolipoprotein A-I rescues carotid arteries from inflammation in vivo JO - Atherosclerosis VL - 196 UR - https://doi.org/10.1016/j.atherosclerosis.2007.05.008 DO - 10.1016/j.atherosclerosis.2007.05.008 ID - Puranik2008 ER - TY - JOUR AU - Yamagishi, S. AU - Adachi, H. AU - Matsui, T. AU - Nakamura, K. AU - Enomoto, M. AU - Fukami, A. AU - Otsuka, M. AU - Kumagae, S. AU - Nanjo, Y. AU - Imaizumi, T. PY - 2009 DA - 2009// TI - Decreased high-density lipoprotein cholesterol level is an independent correlate of circulating tumor necrosis factor-alpha in a general population JO - Clin Cardiol VL - 32 UR - https://doi.org/10.1002/clc.20517 DO - 10.1002/clc.20517 ID - Yamagishi2009 ER - TY - JOUR AU - Bowry, V. W. AU - Stanley, K. K. AU - Stocker, R. PY - 1992 DA - 1992// TI - High density lipoprotein is the major carrier of lipid hydroperoxides in human blood plasma from fasting donors JO - Proc Natl Acad Sci USA VL - 89 UR - https://doi.org/10.1073/pnas.89.21.10316 DO - 10.1073/pnas.89.21.10316 ID - Bowry1992 ER - TY - JOUR AU - Podrez, E. A. PY - 2010 DA - 2010// TI - Anti-oxidant properties of high-density lipoprotein and atherosclerosis JO - Clin Exp Pharmacol Physiol VL - 37 UR - https://doi.org/10.1111/j.1440-1681.2010.05380.x DO - 10.1111/j.1440-1681.2010.05380.x ID - Podrez2010 ER - TY - JOUR AU - Viswambharan, H. AU - Ming, X. F. AU - Zhu, S. AU - Hubsch, A. AU - Lerch, P. AU - Vergères, G. AU - Rusconi, S. AU - Yang, Z. PY - 2004 DA - 2004// TI - Reconstituted high-density lipoprotein inhibits thrombin-induced endothelial tissue factor expression through inhibition of RhoA and stimulation of phosphatidylinositol 3-kinase but not Akt/endothelial nitric oxide synthase JO - Circ Res VL - 94 UR - https://doi.org/10.1161/01.RES.0000124302.20396.B7 DO - 10.1161/01.RES.0000124302.20396.B7 ID - Viswambharan2004 ER - TY - JOUR AU - Nofer, J. R. AU - Brodde, M. F. AU - Kehrel, B. E. PY - 2010 DA - 2010// TI - High-density lipoproteins, platelets and the pathogenesis of atherosclerosis JO - Clin Exp Pharmacol Physiol VL - 37 UR - https://doi.org/10.1111/j.1440-1681.2010.05377.x DO - 10.1111/j.1440-1681.2010.05377.x ID - Nofer2010 ER - TY - JOUR AU - Griffin, J. H. AU - Kojima, K. AU - Banka, C. L. AU - Curtiss, L. K. AU - Fernández, J. A. PY - 1999 DA - 1999// TI - High-density lipoprotein enhancement of anticoagulant activities of plasma protein S and activated protein C JO - J Clin Invest VL - 103 UR - https://doi.org/10.1172/JCI5006 DO - 10.1172/JCI5006 ID - Griffin1999 ER - TY - JOUR AU - Rodríguez, C. AU - González-Díez, M. AU - Badimon, L. AU - Martínez-González, J. PY - 2009 DA - 2009// TI - Sphingosine-1-phosphate: A bioactive lipid that confers high-density lipoprotein with vasculoprotection mediated by nitric oxide and prostacyclin JO - Thromb Haemost VL - 101 ID - Rodríguez2009 ER - TY - JOUR AU - Uittenbogaard, A. AU - Shaul, P. W. AU - Yuhanna, I. S. AU - Blair, A. AU - Smart, E. J. PY - 2000 DA - 2000// TI - High density lipoprotein prevents oxidized low density lipoprotein-induced inhibition of endothelial nitric-oxide synthase localization and activation in caveolae JO - J Biol Chem VL - 275 UR - https://doi.org/10.1074/jbc.275.15.11278 DO - 10.1074/jbc.275.15.11278 ID - Uittenbogaard2000 ER - TY - JOUR AU - Yuhanna, I. S. AU - Zhu, Y. AU - Cox, B. E. AU - Hahner, L. D. AU - Osborne-Lawrence, S. AU - Lu, P. AU - Marcel, Y. L. AU - Anderson, R. G. AU - Mendelsohn, M. E. AU - Hobbs, H. H. AU - Shaul, P. W. PY - 2001 DA - 2001// TI - High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase JO - Nat Med VL - 7 UR - https://doi.org/10.1038/89986 DO - 10.1038/89986 ID - Yuhanna2001 ER - TY - JOUR AU - Franceschini, G. AU - Sirtori, C. R. AU - Capurso, A. AU - Weisgraber, K. H. AU - Mahley, R. W. PY - 1980 DA - 1980// TI - A-IMilano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family JO - J Clin Invest VL - 66 UR - https://doi.org/10.1172/JCI109956 DO - 10.1172/JCI109956 ID - Franceschini1980 ER - TY - JOUR AU - Weisgraber, K. H. AU - Bersot, T. P. AU - Mahley, R. W. AU - Franceschini, G. AU - Magani, D. AU - Sirtori, C. R. PY - 1980 DA - 1980// TI - Isolation and characterization of a cysteine-containing variant of the apoprotein A-1 from high density lipoprotein JO - J Clin Invest VL - 66 UR - https://doi.org/10.1172/JCI109957 DO - 10.1172/JCI109957 ID - Weisgraber1980 ER - TY - JOUR AU - Cimmino, G. AU - Ibanez, B. AU - Vilahur, G. AU - Speidl, W. S. AU - Fuster, V. AU - Badimon, L. AU - Badimon, J. J. PY - 2009 DA - 2009// TI - Up-regulation of reverse cholesterol transport key players and rescue from global inflammation by ApoA-I(Milano) JO - J Cell Mol Med VL - 13 UR - https://doi.org/10.1111/j.1582-4934.2008.00614.x DO - 10.1111/j.1582-4934.2008.00614.x ID - Cimmino2009 ER - TY - JOUR AU - Alexander, E. T. AU - Weibel, G. L. AU - Joshi, M. R. AU - Vedhachalam, C. AU - de la Llera-Moya, M. AU - Rothblat, G. H. AU - Phillips, M. C. AU - Rader, D. J. PY - 2009 DA - 2009// TI - Macrophage reverse cholesterol transport in mice expressing ApoA-I Milano JO - Arterioscler Thromb Vasc Biol VL - 29 UR - https://doi.org/10.1161/ATVBAHA.109.191379 DO - 10.1161/ATVBAHA.109.191379 ID - Alexander2009 ER - TY - JOUR AU - Zhong, S. AU - Sharp, D. S. AU - Grove, J. S. AU - Bruce, C. AU - Yano, K. AU - Curb, J. D. AU - Tall, A. R. PY - 1996 DA - 1996// TI - Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels JO - J Clin Invest VL - 97 UR - https://doi.org/10.1172/JCI118751 DO - 10.1172/JCI118751 ID - Zhong1996 ER - TY - JOUR AU - Matsuura, F. AU - Wang, N. AU - Chen, W. AU - Jiang, X. C. AU - Tall, A. R. PY - 2006 DA - 2006// TI - HDL from CETP-deficient subjects shows enhanced ability to promote cholesterol efflux from macrophages in an apoE- and ABCG1-dependent pathway JO - J Clin Invest VL - 116 UR - https://doi.org/10.1172/JCI27602 DO - 10.1172/JCI27602 ID - Matsuura2006 ER - TY - JOUR AU - Chapman, M. J. AU - Le Goff, W. AU - Guerin, M. AU - Kontush, A. PY - 2010 DA - 2010// TI - Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors JO - Eur Heart J VL - 31 UR - https://doi.org/10.1093/eurheartj/ehp399 DO - 10.1093/eurheartj/ehp399 ID - Chapman2010 ER - TY - JOUR AU - Vasan, R. S. AU - Pencina, M. J. AU - Robins, S. J. AU - Zachariah, J. P. AU - Kaur, G. AU - D'Agostino, R. B. AU - Ordovas, J. M. PY - 2009 DA - 2009// TI - Association of circulating cholesteryl ester transfer protein activity with incidence of cardiovascular disease in the community JO - Circulation VL - 120 UR - https://doi.org/10.1161/CIRCULATIONAHA.109.872705 DO - 10.1161/CIRCULATIONAHA.109.872705 ID - Vasan2009 ER - TY - JOUR AU - Mowri, H. O. AU - Patsch, J. R. AU - Ritsch, A. AU - Föger, B. AU - Brown, S. AU - Patsch, W. PY - 1994 DA - 1994// TI - High density lipoproteins with differing apolipoproteins: relationships to postprandial lipemia, cholesteryl ester transfer protein, and activities of lipoprotein lipase, hepatic lipase, and lecithin: cholesterol acyltransferase JO - J Lipid Res VL - 35 ID - Mowri1994 ER - TY - JOUR AU - Nicholls, S. J. AU - Uno, K. AU - Kataoka, Y. AU - Nissen, S. E. PY - 2011 DA - 2011// TI - ETC-216 for coronary artery disease JO - Expert Opin Biol Ther VL - 11 UR - https://doi.org/10.1517/14712598.2011.557061 DO - 10.1517/14712598.2011.557061 ID - Nicholls2011 ER - TY - JOUR AU - Nicholls, S. J. AU - Tuzcu, E. M. AU - Sipahi, I. AU - Schoenhagen, P. AU - Crowe, T. AU - Kapadia, S. AU - Niossen, S. E. PY - 2006 DA - 2006// TI - Relationship between atheroma regression and change in lumen size after infusion of apolipoprotein A-I Milano JO - J Am Coll Cardiol VL - 47 UR - https://doi.org/10.1016/j.jacc.2005.11.040 DO - 10.1016/j.jacc.2005.11.040 ID - Nicholls2006 ER - TY - JOUR AU - Nissen, S. E. AU - Tsunoda, T. AU - Tuzcu, E. M. AU - Schoenhagen, P. AU - Cooper, C. J. AU - Yasin, M. AU - Eaton, G. M. AU - Lauer, M. A. AU - Sheldon, W. S. AU - Grines, C. L. AU - Halpern, S. AU - Crowe, T. AU - Blankenship, J. C. AU - Kerensky, R. PY - 2003 DA - 2003// TI - Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial JO - JAMA VL - 290 UR - https://doi.org/10.1001/jama.290.17.2292 DO - 10.1001/jama.290.17.2292 ID - Nissen2003 ER - TY - JOUR AU - Navab, M. AU - Anantharamaiah, G. M. AU - Hama, S. AU - Garber, D. W. AU - Chaddha, M. AU - Hough, G. AU - Lallone, R. AU - Fogelman, A. M. PY - 2002 DA - 2002// TI - Oral administration of an Apo A-I mimetic Peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol JO - Circulation VL - 105 UR - https://doi.org/10.1161/hc0302.103711 DO - 10.1161/hc0302.103711 ID - Navab2002 ER - TY - JOUR AU - Weibel, G. L. AU - Alexander, E. T. AU - Joshi, M. R. AU - Rader, D. J. AU - Lund-Katz, S. AU - Phillips, M. C. AU - Rothblat, G. H. PY - 2007 DA - 2007// TI - Wild-type ApoA-I and the Milano variant have similar abilities to stimulate cellular lipid mobilization and efflux JO - Arterioscler Thromb Vasc Biol VL - 27 UR - https://doi.org/10.1161/ATVBAHA.107.148403 DO - 10.1161/ATVBAHA.107.148403 ID - Weibel2007 ER - TY - JOUR AU - Tardif, J. C. AU - Grégoire, J. AU - L'Allier, P. L. AU - Ibrahim, R. AU - Lespérance, J. AU - Heinonen, T. M. AU - Kouz, S. AU - Berry, C. AU - Basser, R. AU - Lavoie, M. A. AU - Guertin, M. C. AU - Rodés-Cabau, J. PY - 2007 DA - 2007// TI - Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial JO - JAMA VL - 297 UR - https://doi.org/10.1001/jama.297.15.jpc70004 DO - 10.1001/jama.297.15.jpc70004 ID - Tardif2007 ER - TY - JOUR AU - Shaw, J. A. AU - Bobik, A. AU - Murphy, A. AU - Kanellakis, P. AU - Blombery, P. AU - Mukhamedova, N. AU - Woollard, K. AU - Lyon, S. AU - Sviridov, D. AU - Dart, A. M. PY - 2008 DA - 2008// TI - Infusion of reconstituted high-density lipoprotein leads to acute changes in human atherosclerotic plaque JO - Circ Res VL - 103 UR - https://doi.org/10.1161/CIRCRESAHA.108.182063 DO - 10.1161/CIRCRESAHA.108.182063 ID - Shaw2008 ER - TY - JOUR AU - Nissen, S. E. AU - Tardif, J. C. AU - Nicholls, S. J. AU - Revkin, J. H. AU - Shear, C. L. AU - Duggan, W. T. AU - Ruzyllo, W. AU - Bachinsky, W. B. AU - Lasala, G. P. AU - Tuzcu, E. M. PY - 2007 DA - 2007// TI - Effect of torcetrapib on the progression of coronary atherosclerosis JO - N Engl J Med VL - 356 UR - https://doi.org/10.1056/NEJMoa070635 DO - 10.1056/NEJMoa070635 ID - Nissen2007 ER - TY - JOUR AU - Barter, P. J. AU - Caulfield, M. AU - Eriksson, M. AU - Grundy, S. M. AU - Kastelein, J. J. AU - Komajda, M. AU - Lopez-Sendon, J. AU - Mosca, L. AU - Tardif, J. C. AU - Waters, D. D. AU - Shear, C. L. AU - Revkin, J. H. AU - Buhr, K. A. AU - Fisher, M. R. AU - Tall, A. R. AU - Brewer, B. PY - 2007 DA - 2007// TI - Effects of torcetrapib in patients at high risk for coronary events JO - N Engl J Med VL - 357 UR - https://doi.org/10.1056/NEJMoa0706628 DO - 10.1056/NEJMoa0706628 ID - Barter2007 ER - TY - JOUR AU - Psaty, B. M. AU - Lumley, T. PY - 2008 DA - 2008// TI - Surrogate end points and FDA approval: a tale of 2 lipid-altering drugs JO - JAMA VL - 299 UR - https://doi.org/10.1001/jama.299.12.1474 DO - 10.1001/jama.299.12.1474 ID - Psaty2008 ER - TY - JOUR AU - Hu, X. AU - Dietz, J. D. AU - Xia, C. AU - Knight, D. R. AU - Loging, W. T. AU - Smith, A. H. AU - Yuan, H. AU - Perry, D. A. AU - Keiser, J. PY - 2009 DA - 2009// TI - Torcetrapib induces aldosterone and cortisol production by an intracellular calcium-mediated mechanism independently of cholesteryl ester transfer protein inhibition JO - Endocrinology VL - 150 UR - https://doi.org/10.1210/en.2008-1512 DO - 10.1210/en.2008-1512 ID - Hu2009 ER - TY - JOUR AU - Stein, E. A. AU - Roth, E. M. AU - Rhyne, J. M. AU - Burgess, T. AU - Kallend, D. AU - Robinson, J. G. PY - 2010 DA - 2010// TI - Safety and tolerability of dalcetrapib (RO4607381/JTT-705): results from a 48-week trial JO - Eur Heart J VL - 31 UR - https://doi.org/10.1093/eurheartj/ehp601 DO - 10.1093/eurheartj/ehp601 ID - Stein2010 ER - TY - JOUR AU - Cannon, C. P. AU - Shah, S. AU - Dansky, H. M. AU - Davidson, M. AU - Brinton, E. A. AU - Gotto, A. M. AU - Stepanavage, M. AU - Liu, S. X. AU - Gibbons, P. AU - Ashraf, T. B. AU - Zafarino, J. AU - Mitchel, Y. AU - Barter, P. PY - 2010 DA - 2010// TI - Safety of anacetrapib in patients with or at high risk for coronary heart disease JO - N Engl J Med VL - 363 UR - https://doi.org/10.1056/NEJMoa1009744 DO - 10.1056/NEJMoa1009744 ID - Cannon2010 ER - TY - JOUR AU - Stroes, E. S. AU - Kastelein, J. J. AU - Bénardeau, A. AU - Kuhlmann, O. AU - Blum, D. AU - Campos, L. A. AU - Clerc, R. G. AU - Nisor, E. J. PY - 2009 DA - 2009// TI - Dalcetrapib: no off-target toxicity on blood pressure or on genes related to the renin-angiotensin-aldosterone system in rats JO - Br J Pharmacol VL - 158 UR - https://doi.org/10.1111/j.1476-5381.2009.00460.x DO - 10.1111/j.1476-5381.2009.00460.x ID - Stroes2009 ER - TY - JOUR AU - Kuivenhoven, J. A. AU - de Grooth, G. J. AU - Kawamura, H. AU - Klerkx, A. H. AU - Wilhelm, F. AU - Trip, M. D. AU - Katelein, J. J. PY - 2005 DA - 2005// TI - Effectiveness of inhibition of cholesteryl ester transfer protein by JTT-705 in combination with pravastatin in type II dyslipidemia JO - Am J Cardiol VL - 95 UR - https://doi.org/10.1016/j.amjcard.2004.12.064 DO - 10.1016/j.amjcard.2004.12.064 ID - Kuivenhoven2005 ER - TY - JOUR AU - Krishna, R. AU - Anderson, M. S. AU - Bergman, A. J. AU - Jin, B. AU - Fallon, M. AU - Cote, J. AU - Rosko, K. AU - Chavez-Eng, C. AU - Lutz, R. AU - Bloomfield, D. M. AU - Gutierrez, M. AU - Doherty, J. AU - Bieberdorf, F. AU - Chodakewitz, J. AU - Gottesdiener, K. M. AU - Wagner, J. A. PY - 2007 DA - 2007// TI - Effect of the cholesteryl ester transfer protein inhibitor, anacetrapib, on lipoproteins in patients with dyslipidaemia and on 24-h ambulatory blood pressure in healthy individuals: two double-blind, randomised placebo-controlled phase I studies JO - Lancet VL - 370 UR - https://doi.org/10.1016/S0140-6736(07)61813-3 DO - 10.1016/S0140-6736(07)61813-3 ID - Krishna2007 ER - TY - JOUR AU - Bloomfield, D. AU - Carlson, G. L. AU - Sapre, A. AU - Tribble, D. AU - McKenney, J. M. AU - Littlejohn, T. W. AU - Sisk, C. M. AU - Mitchel, Y. AU - Pasternak, R. C. PY - 2009 DA - 2009// TI - Efficacy and safety of the cholesteryl ester transfer protein inhibitor anacetrapib as monotherapy and coadministered with atorvastatin in dyslipidemic patients JO - Am Heart J VL - 157 UR - https://doi.org/10.1016/j.ahj.2008.09.022 DO - 10.1016/j.ahj.2008.09.022 ID - Bloomfield2009 ER - TY - JOUR AU - Ricote, M. AU - Valledor, A. F. AU - Glass, C. K. PY - 2004 DA - 2004// TI - Decoding transcriptional programs regulated by PPARs and LXRs in the macrophage: effects on lipid homeostasis, inflammation, and atherosclerosis JO - Arterioscler Thromb Vasc Biol VL - 24 UR - https://doi.org/10.1161/01.ATV.0000103951.67680.B1 DO - 10.1161/01.ATV.0000103951.67680.B1 ID - Ricote2004 ER - TY - JOUR AU - Yu, L. AU - York, J. AU - von Bergmann, K. AU - Lutjohann, D. AU - Cohen, J. C. AU - Hobbs, H. H. PY - 2003 DA - 2003// TI - Stimulation of cholesterol excretion by the liver × receptor agonist requires ATP-binding cassette transporters G5 and G8 JO - J Biol Chem VL - 278 UR - https://doi.org/10.1074/jbc.M301311200 DO - 10.1074/jbc.M301311200 ID - Yu2003 ER - TY - JOUR AU - Venkateswaran, A. AU - Laffitte, B. A. AU - Joseph, S. B. AU - Mak, P. A. AU - Wilpitz, D. C. AU - Edwards, P. A. AU - Tontonoz, P. PY - 2000 DA - 2000// TI - Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha JO - Proc Natl Acad Sci USA VL - 97 UR - https://doi.org/10.1073/pnas.200367697 DO - 10.1073/pnas.200367697 ID - Venkateswaran2000 ER - TY - JOUR AU - Naik, S. U. AU - Wang, X. AU - Da Silva, J. S. AU - Jaye, M. AU - Macphee, C. H. AU - Reilly, M. P. AU - Billheimer, J. T. AU - Rothblat, G. H. AU - Rader, D. J. PY - 2006 DA - 2006// TI - Pharmacological activation of liver × receptors promotes reverse cholesterol transport in vivo JO - Circulation VL - 113 UR - https://doi.org/10.1161/CIRCULATIONAHA.105.560177 DO - 10.1161/CIRCULATIONAHA.105.560177 ID - Naik2006 ER - TY - JOUR AU - Peng, D. AU - Hiipakka, R. A. AU - Xie, J. T. AU - Dai, Q. AU - Kokontis, J. M. AU - Reardon, C. A. AU - Getz, G. S. AU - Liao, S. PY - 2011 DA - 2011// TI - A novel potent synthetic steroidal liver × receptor agonist lowers plasma cholesterol and triglycerides and reduces atherosclerosis in LDLR(-/-) mice JO - Br J Pharmacol VL - 162 UR - https://doi.org/10.1111/j.1476-5381.2011.01202.x DO - 10.1111/j.1476-5381.2011.01202.x ID - Peng2011 ER - TY - JOUR AU - Cha, J. Y. AU - Repa, J. J. PY - 2007 DA - 2007// TI - The liver × receptor (LXR) and hepatic lipogenesis. The carbohydrate-response element-binding protein is a target gene of LXR JO - J Biol Chem VL - 282 UR - https://doi.org/10.1074/jbc.M605023200 DO - 10.1074/jbc.M605023200 ID - Cha2007 ER - TY - JOUR AU - Braun, A. AU - Trigatti, B. L. AU - Post, M. J. AU - Sato, K. AU - Simons, M. AU - Edelberg, J. M. AU - Rosenberg, R. D. AU - Schrenzel, M. AU - Krieger, M. PY - 2002 DA - 2002// TI - Loss of SR-BI expression leads to the early onset of occlusive atherosclerotic coronary artery disease, spontaneous myocardial infarctions, severe cardiac dysfunction, and premature death in apolipoprotein E-deficient mice JO - Circ Res VL - 90 UR - https://doi.org/10.1161/hh0302.104462 DO - 10.1161/hh0302.104462 ID - Braun2002 ER - TY - JOUR AU - Masson, D. AU - Koseki, M. AU - Ishibashi, M. AU - Larson, C. J. AU - Miller, S. G. AU - King, B. D. AU - Tall, A. R. PY - 2009 DA - 2009// TI - Increased HDL cholesterol and apoA-I in humans and mice treated with a novel SR-BI inhibitor JO - Arterioscler Thromb Vasc Biol VL - 29 UR - https://doi.org/10.1161/ATVBAHA.109.191320 DO - 10.1161/ATVBAHA.109.191320 ID - Masson2009 ER -